|1.||Wu, Qi: 2 articles (06/2011 - 06/2009)|
|2.||Palmiter, Richard D: 2 articles (06/2011 - 06/2009)|
|3.||Löscher, Wolfgang: 1 article (01/2014)|
|4.||Rundfeldt, Chris: 1 article (01/2014)|
|5.||Skolnick, Phil: 1 article (11/2012)|
|6.||Giusti, Pietro: 1 article (06/2010)|
|7.||Guidotti, Alessandro: 1 article (06/2010)|
|8.||Auta, James: 1 article (06/2010)|
|9.||Kadriu, Bashkim: 1 article (06/2010)|
|10.||Costa, Erminio: 1 article (06/2010)|
12/01/2001 - "Bretazenil, a benzodiazepine receptor partial agonist, as an adjunct in the prophylactic treatment of OP poisoning."
12/01/2001 - "At the anticonvulsive doses (125-250 microg x kg(-1), i.p.) bretazenil, in combination with pyridostigmine (100 microg x kg(-1), i.m.) and aprophen (4 mg x kg(-1), i.m.), conferred prophylactic protection against sarin and soman poisoning (protective ratios 2.6 and 2.1, respectively). "
|2.||Schizophrenia (Dementia Praecox)
01/01/1995 - "Initial clinical results with bretazenil (Ro 16-6028), a partial BDZ agonist, in acute schizophrenia are, in this respect, an encouraging lead to be followed further."
07/01/1996 - "Antipsychotic effects of bretazenil, a partial benzodiazepine agonist in acute schizophrenia--a study group report."
11/01/2012 - "In contrast to the anxioselective profile displayed in preclinical models, compounds such as bretazenil, TPA023, and MRK 409 produced benzodiazepine-like side effects (sedation, dizziness) in Phase I studies, whereas alpidem and ocinaplon exhibited many of the characteristics of an anxioselective in the clinic. "
07/01/2006 - "Bretazenil was able to decrease the duration of afterdischarges as well as intensity of clonic seizures accompanying these afterdischarges in all age groups in a dose-dependent manner. "
11/01/1995 - "Bretazenil (10 mg/kg twice daily for 6 days) produced no tolerance in any of the seizure models, but a significant decrease in electroshock seizure threshold was seen in the withdrawal period. "
11/01/1993 - "The youngest rats exhibited maximal effects of Ro 16-6028 against major seizures. "
11/01/1993 - "Major seizures were always more sensitive to Ro 16-6028 than were minimal seizures. "
12/01/2001 - "Bretazenil, a partial agonist, was found to counteract metrazol-induced convulsions in rats. "
09/01/1999 - "Under the schedule of stimulus-shock termination, midazolam produced dose-related decreases in response rate, and these effects were surmountably antagonized by flumazenil, bretazenil, Ro 41-7812, Ro 42-8773, and beta-CCt. "
09/01/1994 - "Discontinuation of long-term treatment with diazepam or triazolam, but not of long-term treatment with imidazenil or bretazenil, sensitized rats to behavioral inhibition by punishment (electric shock) in a manner that was potentiated by flumazenil. "
|3.||Pyridostigmine Bromide (Pyridostigmine)
|7.||7- (1,1- dimethylethyl)- 6- (2- ethyl- 2H- 1,2,4- triazol- 3- ylmethoxy)- 3- (2- fluorophenyl)- 1,2,4- triazolo(4,3- b)pyridazine
|9.||GABA-A Receptors (GABA(A) Receptor)